Biomedical Companies

Shares of Cellular Biomedicine Group Inc (NASDAQ: CBMG), a biomedical company that is engaged in the development of new treatments for cancerous and degenerative diseases, surged by more than 6 percent on Thursday. Cellular Biomedicine announced it has received a $43.13 million investment from...